Pin Lean is a Senior Lecturer (Associate Professor) in Bio-Law at Brunel Law School, Brunel University London. A former practising barrister and solicitor, she was a corporate-commercial attorney working primarily in corporate finance, mergers and acquisitions, technology law, and general corporate advisory matters. Prior to joining Brunel University, she was an attorney on secondment with the Legal Services Team (based in Belgrave, London) in the General Counsel's Organization of American Express International, where she was a key senior legal counsel for the Asia-Pacific region.
Pin Lean is the General Manager of the Centre for Artificial Intelligence: Social & Digital Innovations. She is an active member of the Brunel International Law Research Group, Living Avatars Research Group, the Human Rights, Society and the Arts Research Group, and Reproduction Research Group. Externally, she is part of the ELSI2.0 Workspace, an international collaboratory on genomics and society research; a member of the European Association of Health Law (EAHL), and a General Manager of the Interest Group on Supranational Bio-Law of the EAHL; and a member of the Daughters of Themis: International Network of Women Business Scholars. She has held visiting fellowships with the Centre for Health, Law and Emerging Technologies (HeLEX), NDPH (Medical Sciences Division), University of Oxford; the Centre for Ethics and Law in the Life Sciences (CELLs) at the University of Hannover, Germany; and participated in the Centre for Ethics and Law in Biomedicine (CELAB) in Central European University, Hungary.
Pin Lean also leads the UK & European chapter of the global Responsible Metaverse Alliance as Director of Research; and is an invited member of the United Nations (UN) International Telecommunications Union (ITU) Working Group on the Metaverse, focusing on competition, economics, standards and regulatory aspects of the Metaverse.
Her research encompasses European, international, and comparative law for genome editing (with a focus on pre-implantation genetic diagnosis, reproductive technologies and women's bodies; and the proliferation of virulent gene-edited pathogens and global bio-security); propertization and commodification studies of genetic materials and biomedical technologies; the ethico-legal governance for artificial intelligence (AI) systems (with a focus on protection of fundamental rights, spatial 'body citizenship' and bio-constitutional implications of the AI-augmented biological human body, and AI in women's health); and technologies horizon scanning and legal future foresighting for new and emerging technologies and environments, such as the Metaverse. She has written widely on topics straddling the fringes of laws, technologies and society, and has been invited as a speaker by many national and international organisations, including on podcasts relating to technologies, and media interviews with news organisations in the UK, US, France, Germany, Brazil, Hungary, Malaysia, Japan, and India. Recently, she was invited as an expert panelist by the UK regulatory alliance, the Digital Cooperation Regulation Forum (DRCF) in its first Metaverse Symposium. She has also consulted as an expert with the UK Law Society on technologies and horizon scanning in its Future Worlds 2050 Project.